Latest News
Study finds bone injections don’t improve survival over IV in cardiac arrest treatment
Administrating life-saving drugs for cardiac arrest directly into the bone does not improve survival rates compared to the standard intravenous (IV) method according to new research from Warwick Medical School in partnership with NHS Ambulance Services.
Warwick Medical School leads two revolutionary trials
WMS is leading two revolutionary trials that will compare the treatment benefits of traditional physiotherapy rehabilitation with transplanted knee surgeries.
WMS study reveals cardiac arrest figures in England
A national research database led by the Clinical Trials Unit at WMS has revealed stark figures for cardiac arrests in England for 2022, with just 1 in 12 people surviving 30 days after an out-of-hospital cardiac arrest.
Appointment of Professor Charles Craddock
Warwick Medical School is delighted to welcome the new appointment of Professor Charles Craddock CBE to the Clinical Trials Unit as Professor of Haemato-Oncology. Professor Craddock will take a lead role in developing high-quality research programmes in clinical and cost effectiveness research of cancer therapies and support the University’s work on Innovation particularly in the health theme including the development of the University’s supra-regional health innovation campus Arden Cross and other projects - Read more here.
Hunterian Professor Award to Dr Hannah James
Dr Hannah James, Specialist Registrar in Trauma & Orthopaedic Surgery at UHCW and PhD graduate from Warwick Clinical Trials Unit has been awarded a very prestigious Hunterian Professorship by the Royal College of Surgeons for her ground breaking surgical education research work.
Dr James recently completed an outstanding body of research for her PhD on the impact of cadaveric surgical training on improving patient outcomes. She becomes the first female Trauma and Orthopaedic (T&O) surgeon to become a Hunterian Professor. Read the full article here